Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Respiratory Medicine Case Reports|October 27, 2023
Tolerability of sotorasib for KRAS positive lung adenocarcinoma patient with pre-existing interstitial pneumonia; A case reportKohei Okada, Rie Sakakibara, Takayuki Honda, et al.Respiratory Investigation|September 24, 2025
Cluster analysis of seasonal KL-6 variations in interstitial lung diseasesYuki Iijima, Tsukasa Okamoto, Shiro Sonoda, et al.Respiratory Investigation|September 8, 2015
Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitisToshiharu Tsutsui, Yasunari Miyazaki, Tsukasa Okamoto, et al.Chest|February 3, 2016
Chronic Hypersensitivity Pneumonitis With a Usual Interstitial Pneumonia-Like Pattern: Correlation Between Histopathologic and Clinical FindingsSahoko Chiba, Kimitake Tsuchiya, Takumi Akashi, et al.Allergology International : Official Journal of the Japanese Society of Allergology|March 16, 2019
Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitisYoshihisa Nukui, Yasunari Miyazaki, Masahiro Masuo, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|July 26, 2022
Muc5b plays a role in the development of inflammation and fibrosis in hypersensitivity pneumonitis induced by Saccharopolyspora rectivirgulaTsukasa Okamoto, Evgenia Dobrinskikh, Corinne E Hennessy, et al.Respiratory Investigation|September 11, 2025
Impact of medications on lung function in fibrotic hypersensitivity pneumonitisTakemoto Abe, Tsukasa Okamoto, Takashi Shimamura, et al.Internal Medicine (Tokyo, Japan)|February 8, 2023
COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung DiseaseTomoya Tateishi, Sho Shimada, Takashi Yamana, et al.Immunotherapy|May 5, 2020
Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case reportYuki Iijima, Rie Sakakibara, Masahiro Ishizuka, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 1, 2020
MuLBSTA score is a useful tool for predicting COVID-19 disease behaviorYuki Iijima, Tsukasa Okamoto, Tsuyoshi Shirai, et al.Pageof 6